[go: up one dir, main page]

NO20020161D0 - Vitamin D3-analoger - Google Patents

Vitamin D3-analoger

Info

Publication number
NO20020161D0
NO20020161D0 NO20020161A NO20020161A NO20020161D0 NO 20020161 D0 NO20020161 D0 NO 20020161D0 NO 20020161 A NO20020161 A NO 20020161A NO 20020161 A NO20020161 A NO 20020161A NO 20020161 D0 NO20020161 D0 NO 20020161D0
Authority
NO
Norway
Prior art keywords
analogues
vitamin
Prior art date
Application number
NO20020161A
Other languages
English (en)
Other versions
NO20020161L (no
Inventor
Andrew David Batcho
Bernard Michael Hennessy
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20020161L publication Critical patent/NO20020161L/no
Publication of NO20020161D0 publication Critical patent/NO20020161D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20020161A 1999-07-12 2002-01-11 Vitamin D3-analoger NO20020161D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14341399P 1999-07-12 1999-07-12
PCT/EP2000/006393 WO2001004089A1 (en) 1999-07-12 2000-07-06 Vitamin d3 analogs

Publications (2)

Publication Number Publication Date
NO20020161L NO20020161L (no) 2002-01-11
NO20020161D0 true NO20020161D0 (no) 2002-01-11

Family

ID=22503954

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020161A NO20020161D0 (no) 1999-07-12 2002-01-11 Vitamin D3-analoger

Country Status (36)

Country Link
US (1) US6331642B1 (no)
EP (1) EP1200399B1 (no)
JP (1) JP3803579B2 (no)
KR (1) KR100477161B1 (no)
CN (1) CN1174964C (no)
AR (1) AR024695A1 (no)
AT (1) ATE262508T1 (no)
AU (1) AU779408B2 (no)
BR (1) BR0012419A (no)
CA (1) CA2378803C (no)
CO (1) CO5190683A1 (no)
DE (1) DE60009303T2 (no)
DK (1) DK1200399T3 (no)
EG (1) EG23909A (no)
ES (1) ES2215707T3 (no)
GC (1) GC0000198A (no)
HK (1) HK1047578B (no)
HR (1) HRP20020007A2 (no)
HU (1) HUP0202157A3 (no)
IL (2) IL147254A0 (no)
JO (1) JO2255B1 (no)
MA (1) MA26808A1 (no)
MX (1) MXPA02000313A (no)
MY (1) MY122633A (no)
NO (1) NO20020161D0 (no)
NZ (1) NZ516339A (no)
PE (1) PE20010328A1 (no)
PL (1) PL201877B1 (no)
PT (1) PT1200399E (no)
RS (1) RS50229B (no)
RU (1) RU2235721C2 (no)
TR (1) TR200200054T2 (no)
TW (1) TWI268276B (no)
UY (1) UY26239A1 (no)
WO (1) WO2001004089A1 (no)
ZA (1) ZA200110487B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001278744A1 (en) * 2000-08-17 2002-02-25 Chugai Seiyaku Kabushiki Kaisha Remedial agent for osteoporosis
ATE334986T1 (de) 2000-10-02 2006-08-15 Univ Emory Triptpolidanaloge zur verendung in der behandlung von autoimmunbedingten und entzündlichen erkrankungen
WO2003027065A1 (en) * 2001-09-21 2003-04-03 F. Hoffmann-La Roche Ag 3-desoxy-vitamin d3 analog esters
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
WO2004098522A2 (en) * 2003-04-30 2004-11-18 Bioxell S.P.A. Gemini vitamin d3 compounds and methods of use thereof
US20050113348A1 (en) * 2003-06-12 2005-05-26 Yanchun Li Vitamin D and vitamin D analogs or derivatives as new anti-hypertensive agents
GB2407499B (en) * 2003-11-03 2008-02-27 Bioxell Spa Vitamin D3 analogue for use in the treatment of BPH
SG110107A1 (en) * 2003-09-24 2005-04-28 Bioxell Spa Compound and use in treatment
BRPI0414701A (pt) * 2003-09-24 2006-11-14 Bioxell Spa uso de um composto de vitamina d, método de prevenção ou tratamnento de disfunção de bexiga em um paciente, composto de vitamina d, e, kit
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
US20080318911A1 (en) * 2004-09-24 2008-12-25 Bioxell S.P.A. 20-Cyclopropyl, 26,27-Alkyl/Haloalkyl Vitamin D3 Compounds and Methods of Use Thereof
JP2008519808A (ja) 2004-11-12 2008-06-12 ビオエクセル エスピーエー 膀胱癌治療のためのビタミンｄ誘導体及び抗増殖薬の併用
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
ES2544819T3 (es) * 2007-05-30 2015-09-04 Opko IP Holdings II, Inc. Proceso para la producción de precursores de la vitamina D de óxido de fosfina
WO2009125825A1 (ja) 2008-04-11 2009-10-15 中外製薬株式会社 複数分子の抗原に繰り返し結合する抗原結合分子
JP5950413B2 (ja) * 2011-03-02 2016-07-13 学校法人日本大学 パーシャルアゴニスト活性を持つ新規ビタミンｄ受容体モジュレーター
KR102523660B1 (ko) 2016-09-26 2023-04-19 (주)하이플 박스용 테두리 부재보강부재와 에셈블리컨테이너 원터치크립이 포함된 박스

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749710A (en) 1985-05-01 1988-06-07 Hoffmann-La Roche Inc. Immunosuppressive agents
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5401733A (en) * 1993-10-01 1995-03-28 Hoffmann-La Roche Inc. Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US6040300A (en) * 1995-04-07 2000-03-21 Arch Development Corporation Method of preventing colon cancer with vitamin D3 analogues
AU708679B2 (en) 1996-03-21 1999-08-12 F. Hoffmann-La Roche Ag 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives

Also Published As

Publication number Publication date
US6331642B1 (en) 2001-12-18
KR100477161B1 (ko) 2005-03-18
JO2255B1 (en) 2004-10-07
PE20010328A1 (es) 2001-03-22
DK1200399T3 (da) 2004-07-19
HK1047578B (zh) 2005-04-29
AU6689400A (en) 2001-01-30
JP2003504354A (ja) 2003-02-04
HUP0202157A2 (en) 2002-10-28
PL356124A1 (en) 2004-06-14
CA2378803A1 (en) 2001-01-18
TWI268276B (en) 2006-12-11
ES2215707T3 (es) 2004-10-16
PL201877B1 (pl) 2009-05-29
TR200200054T2 (tr) 2002-06-21
CO5190683A1 (es) 2002-08-29
NO20020161L (no) 2002-01-11
AR024695A1 (es) 2002-10-23
YU92701A (sh) 2004-09-03
ZA200110487B (en) 2003-03-20
KR20020033728A (ko) 2002-05-07
MXPA02000313A (es) 2002-06-21
RS50229B (sr) 2009-07-15
DE60009303D1 (de) 2004-04-29
CA2378803C (en) 2009-01-27
IL147254A0 (en) 2002-08-14
UY26239A1 (es) 2000-10-31
HUP0202157A3 (en) 2004-04-28
MA26808A1 (fr) 2004-12-20
RU2235721C2 (ru) 2004-09-10
GC0000198A (en) 2006-03-29
NZ516339A (en) 2003-07-25
HRP20020007A2 (en) 2003-04-30
EP1200399A1 (en) 2002-05-02
CN1174964C (zh) 2004-11-10
EP1200399B1 (en) 2004-03-24
EG23909A (en) 2007-12-30
HK1047578A1 (en) 2003-02-28
JP3803579B2 (ja) 2006-08-02
IL147254A (en) 2006-07-05
CN1360572A (zh) 2002-07-24
ATE262508T1 (de) 2004-04-15
DE60009303T2 (de) 2005-02-24
MY122633A (en) 2006-04-29
BR0012419A (pt) 2002-03-26
WO2001004089A1 (en) 2001-01-18
PT1200399E (pt) 2004-06-30
AU779408B2 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
DK1124779T3 (da) D-vitaminanaloge forbindelser
DK1235777T3 (da) Vitamin D-analoger
NO994094D0 (no) Stigerörsanordning
ID26447A (id) Turunan eritropoietin
NO20022856L (no) Adamtanderivater
ATA51899A (de) Handstempel
DE69935620D1 (de) Aufzug
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
DK0808833T3 (da) D3-vitamin-analoger
DK1200399T3 (da) Vitamin D3-analoger
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
DK1235824T3 (da) D-vitaminanaloge forbindelser
DE50005038D1 (de) Vorsteuergerät
DE69940408D1 (de) Rolltreppe
ID30214A (id) Turunan resorsinol
PT1167260E (pt) Derivados de vitamina d3
DE60007483D1 (de) Aufzug
DE50002350D1 (de) Hubschrauber
ATE269311T1 (de) Benzoylpyridazine
ATA121799A (de) Ausbeulgerät
PL356301A1 (en) Novel vitamin d analogues
ATA107599A (de) Heizwasserbereiter
DE60010173D1 (de) Schlichtevorrichtung
ATA732000A (de) Kachelofen
NO20021128D0 (no) L-selektinkontrastmidler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application